| # | Drug | Count |
|---|---|---|
| 0 | DASATINIB | 64 |
| 1 | LENALIDOMIDE | 61 |
| 2 | ECULIZUMAB | 48 |
| 3 | ENTECAVIR | 43 |
| 4 | SODIUM OXYBATE | 43 |
| 5 | THALIDOMIDE | 42 |
| 6 | ISOTRETINOIN | 38 |
| 7 | NIVOLUMAB | 34 |
| 8 | FINASTERIDE | 27 |
| 9 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DASATINIB | 64 | 0.0069 |
| 1 | ENTECAVIR | 43 | 0.0036 |
| 2 | NAFCILLIN SODIUM | 2 | 0.0022 |
| 3 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 4 | RESLIZUMAB | 1 | 0.0015 |
| 5 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 6 | TRIAZOLAM | 5 | 0.0012 |
| 7 | THALIDOMIDE | 42 | 0.0011 |
| 8 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 26 | 0.0011 |
| 9 | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 1 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Complement Inhibitor [EPC] | 58 | 0.0010 |
| 2 | Cardiac Myosin Inhibitor [EPC] | 5 | 0.0008 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 4 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 25 | 0.0005 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 45 | 0.0005 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 22 | 0.0004 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |